What Causes Parathyroid Nodules?
Parathyroid nodules are primarily caused by autonomous parathyroid adenomas (80% of cases), followed by multigland disease including multiple adenomas or parathyroid hyperplasia (15-20%), and rarely parathyroid carcinoma (<1%). 1
Primary Causes
Sporadic Disease (Most Common)
The vast majority of parathyroid nodules occur sporadically without identifiable genetic predisposition. A single parathyroid adenoma accounts for approximately 80% of all cases, representing autonomous overproduction of parathyroid hormone (PTH) by one gland 1. These adenomas develop through mechanisms that remain incompletely understood but result in unregulated PTH secretion and subsequent hypercalcemia.
Multigland Disease (15-20%)
Multigland disease encompasses:
- Multiple adenomas: Two or more distinct adenomas in separate glands
- Parathyroid hyperplasia: Enlargement of three or all four parathyroid glands
This pattern is more common in hereditary syndromes but can occur sporadically 1.
Parathyroid Carcinoma (<1%)
This rare malignant cause presents with more severe hypercalcemia and has distinct histological features including capsular invasion and loss of parafibromin expression 2.
Secondary Causes: Hereditary Syndromes
Multiple Endocrine Neoplasia Type 1 (MEN1)
MEN1 predisposes to parathyroid nodules, typically presenting as multigland disease. Annual calcium and phosphate monitoring is recommended for all MEN1 patients aged 10 and over 2. These patients often develop parathyroid involvement at younger ages (<50 years) and have higher recurrence rates after surgery.
Multiple Endocrine Neoplasia Type 2A (MEN2A)
MEN2A patients require annual hyperparathyroidism screening. The parathyroid involvement follows similar surgical indications as sporadic disease 2.
Hyperparathyroidism-Jaw Tumor Syndrome (HPT-JT)
Caused by CDC73 gene mutations, this syndrome presents with:
- Parathyroid adenomas or carcinomas (90% of mutated subjects, often presenting in adolescence or early adulthood)
- 15-20% risk of parathyroid carcinoma - the highest among hereditary syndromes
- Characteristic histological features: cystic appearance, eosinophilic cytoplasm, nuclear enlargement, thick capsule
- High recurrence risk of approximately 25% at 5-25 years 2
Familial Hypocalciuric Hypercalcemia (FHH)
While technically not causing true parathyroid nodules, FHH mutations can mimic primary hyperparathyroidism and must be excluded through genetic testing when hypercalcemia occurs with inappropriately low urinary calcium 3.
Secondary Hyperparathyroidism Leading to Nodular Change
Chronic kidney disease is the most common cause of secondary hyperparathyroidism, where prolonged stimulation from hypocalcemia and hyperphosphatemia leads to parathyroid hyperplasia 1. Other causes include:
- Malabsorption syndromes
- Vitamin D deficiency
- Inadequate calcium intake
These conditions cause reactive parathyroid enlargement rather than autonomous adenomas 1.
Rare Cause: Parathyromatosis
Parathyromatosis consists of multiple small nodules of hyperfunctional parathyroid tissue scattered throughout the neck and/or mediastinum 4, 5, 6. This exceptional entity arises from:
- Surgical seeding: Capsular rupture during prior parathyroidectomy causing tissue spillage (most common mechanism)
- Embryologic remnants: Overgrowth of pre-existing parathyroid rests 4, 6, 7
Parathyromatosis typically manifests 1-17 years after initial parathyroid surgery and represents a challenging cause of persistent or recurrent hyperparathyroidism 5.
Clinical Pitfalls
Important caveat: Ectopic parathyroid adenomas (9-22% of cases) may be located within the thyroid gland itself, mimicking thyroid nodules on imaging and potentially leading to misdiagnosis 8. When a thyroid nodule shows 99mTc-MIBI uptake or has indeterminate cytology, routine evaluation of calcium-phosphorus metabolism should be performed to avoid missing an intrathyroidal parathyroid adenoma 8.
The diagnosis of parathyroid nodules causing hyperparathyroidism is biochemical (elevated serum calcium with inappropriately normal or elevated PTH), not imaging-based. Imaging serves only to localize abnormal glands for surgical planning, not to confirm diagnosis 1.